Proline dehydrogenase deficiency
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
An atlas of genetic influences on human blood metabolites.
|
24816252 |
2014 |
Proline dehydrogenase deficiency
|
0.770 |
GermlineCausalMutation
|
disease |
ORPHANET |
Type I hyperprolinemia is caused by a proline oxidase deficiency, which is encoded by the PRODH gene on chromosome 22q11.
|
23462603 |
2013 |
Proline dehydrogenase deficiency
|
0.770 |
GermlineCausalMutation
|
disease |
ORPHANET |
The goals of this study were first to measure in controls the frequency of PRODH variations described in HPI patients, second to assess the functional effect of PRODH mutations on POX activity, and finally to establish genotype/enzymatic activity correlations in a new series of HPI patients.
|
20524212 |
2010 |
Proline dehydrogenase deficiency
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
We screened four Italian children with HPI presenting epilepsy, mental retardation, and behavioral disorders for PRODH gene mutations, and attempted a genotype-phenotype correlation.
|
18197084 |
2008 |
Proline dehydrogenase deficiency
|
0.770 |
Biomarker
|
disease |
BEFREE |
Hyperprolinemia type I (HPI) is a result of a deficiency in POX.
|
18806117 |
2008 |
Proline dehydrogenase deficiency
|
0.770 |
Biomarker
|
disease |
BEFREE |
Hyperprolinemia type I (HPI) results from a deficiency of proline oxidase (POX), involved in the first step in the conversion of proline to glutamate.
|
17412540 |
2007 |
Proline dehydrogenase deficiency
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
Finally, from the extensive analysis of the PRODH gene coding sequence variations, it is predicted that POX residual activity in the 0-30% range results into HPI, whereas residual activity in the 30-50% range is associated either with normal plasma proline levels or with mild-to-moderate hyperprolinemia.
|
17135275 |
2007 |
Proline dehydrogenase deficiency
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
Finally, from the extensive analysis of the PRODH gene coding sequence variations, it is predicted that POX residual activity in the 0-30% range results into HPI, whereas residual activity in the 30-50% range is associated either with normal plasma proline levels or with mild-to-moderate hyperprolinemia.
|
17135275 |
2007 |
Proline dehydrogenase deficiency
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
At least 16 PRODH missense mutations have been identified in studies of type I hyperprolinemia (HPI) and schizophrenia, 10 of which are present at polymorphic frequencies.
|
15662599 |
2005 |
Proline dehydrogenase deficiency
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
At least 16 PRODH missense mutations have been identified in studies of type I hyperprolinemia (HPI) and schizophrenia, 10 of which are present at polymorphic frequencies.
|
15662599 |
2005 |
Proline dehydrogenase deficiency
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
PRODH mutations and hyperprolinemia in a subset of schizophrenic patients.
|
12217952 |
2002 |
Proline dehydrogenase deficiency
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
These observations demonstrate that type I hyperprolinemia is present in a subset of schizophrenic patients, and suggest that the genetic determinism of type I hyperprolinemia is complex, the severity of hyperprolinemia depending on the nature and number of hits affecting the PRODH locus.
|
12217952 |
2002 |
Proline dehydrogenase deficiency
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
PRODH mutations and hyperprolinemia in a subset of schizophrenic patients.
|
12217952 |
2002 |
Proline dehydrogenase deficiency
|
0.770 |
Biomarker
|
disease |
BEFREE |
A human homologue of the Drosophila melanogaster sluggish-A (proline oxidase) gene maps to 22q11.2, and is a candidate gene for type-I hyperprolinaemia.
|
9385373 |
1997 |
Proline dehydrogenase deficiency
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
Association of hyperprolinaemia type I and heparin cofactor II deficiency with CATCH 22 syndrome: evidence for a contiguous gene syndrome locating the proline oxidase gene.
|
8803768 |
1996 |
Proline dehydrogenase deficiency
|
0.770 |
Biomarker
|
disease |
CTD_human |
|
|
|
Proline dehydrogenase deficiency
|
0.770 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Proline dehydrogenase deficiency
|
0.770 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Proline dehydrogenase deficiency
|
0.770 |
SusceptibilityMutation
|
disease |
CLINVAR |
|
|
|
Schizophrenia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
These results imply that PPI might be modulated by four genotypes - COMT rs4680 (primarily in males), GRIK3 rs1027599, TCF4 rs9960767, and PRODH rs385440 - indicating a role of these gene variations in the development of early information processing deficits in schizophrenia.
|
29287625 |
2018 |
Schizophrenia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
This meta-analysis suggests that rs372055 (C/T) polymorphism in PRODH gene is associated with increased SZ risk only in Asian.
|
29047040 |
2018 |
Schizophrenia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Mutations in the proline dehydrogenase gene <i>PRODH</i> are linked to behavioral alterations in schizophrenia and as part of DiGeorge and velo-cardio-facial syndromes, but the role of PRODH in their etiology remains unclear.
|
28331058 |
2017 |
Schizophrenia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The proline dehydrogenase (PRODH) gene, which encodes the enzyme that catalyzes proline catabolism, maps to human chromosome 22q11.2, a region conferring risk of schizophrenia.
|
27622935 |
2016 |
Schizophrenia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Therefore, our study investigates the effects of 12 polymorphisms of PRODH on schizophrenia and its phenotypes.
|
24498354 |
2014 |
Schizophrenia
|
0.500 |
Biomarker
|
disease |
BEFREE |
PRODH maps to chromosome 22q11, a region conferring the highest known genetic risk of schizophrenia, and encodes proline oxidase, which catalyzes proline catabolism. l-Proline is a neuromodulator at glutamatergic synapses, and peripheral hyperprolinemia has been associated with decreased IQ, cognitive impairment, schizoaffective disorder, and schizophrenia.
|
24787057 |
2014 |